Gland Pharma`s Generic Edaravone Receives Approval in the U.S
Gland Pharma`s Generic Tranexamic Acid Receives Approval in the U.S
Gland Pharma's Generic Magnesium Sulfate Receives Approval in the U.S
Gland Pharma`s Generic Vasopressin Receives Approval in the U.S.
Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.
Gland Pharma`s Generic Angiotensin II Receives Approval in the U.S.
BENGALURU, Nov 6 (Reuters) - Indian generic injectables maker Gland Pharma (GLAD.NS) posted a weaker-than-expected second-quarter profit on Monday, as higher employee expenses eclipsed strong sales in key markets.
The U.S. Food and Drug Administration U.S. (FDA) has issued a Form 483 to Gland Pharma with two observations after a pre-market inspection of the generic injectables maker’s Pashamylaram facility in Hyderabad.
Gland Pharma's Generic Dihydroergotamine Mesylate Receives Approval in the U.S.